| Fund Name | Location |
| Angular Ventures | England, London, United Kingdom |
| Charmides Capital | Carmel, Indiana, United States |
| CSAA Insurance Group | California, United States, Walnut Creek |
| FG II Ventures | Connecticut, Greenwich, United States |
| FPInnovations | Canada, Pointe-Claire, Quebec |
| G+J Digital Ventures | - |
| Grapeseed.Bio | La Fayette, New York, United States |
| Impact Partenaires | France, Ile-de-France, Paris |
| LYVC | California, San Mateo, United States |
| Metropolis Venture Partners | New York, New York, United States |
| Nantong Lanwan Chuangtou | China, Haimen, Jiangsu |
| Shenzhen Qianhai Rengong Zhineng Liuhao Touzi | China, Guangdong, Shenzhen |
| SkyKnight Capital | California, San Francisco, United States |
| Stic Investment | Seoul, Seoul-t'ukpyolsi, South Korea |
| STIHL Digital | Baden-Wurttemberg, Germany, Waiblingen |
| UC Berkeley, Haas Business School | Berkeley, California, United States |
| Wadi Makkah Ventures | - |
| Yinying Ziben | Beilun, China, Zhejiang |
| Zillow | Seattle, United States, Washington |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Osmind | $2M | 14 Oct 2020 | Mountain View, California, United States | ||
OM1 | $15M | 06 Apr 2017 | Boston, Massachusetts, United States |
– OM1, a Boston MA-based health technology company, raised $85M in funding.
– The round was led by D1 Capital Partners, Kaiser Permanente, and Breyer Capital with participation from General Catalyst (GC), Polaris Partners, Scale Venture Partners, 7wire Ventures, and Glikvest.
– The new investment will be used to expand its real-world data cloud, clinical registries, and AI platform for real-world evidence and personalized medicine.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Osmind | $2M | 14 Oct 2020 | Mountain View, California, United States | ||
OM1 | $15M | 06 Apr 2017 | Boston, Massachusetts, United States |
